Anti-SLC35E2B monoclonal antibody
Pre-made anti-SLC35E2B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to SLC35E2B/SLC35E2B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP1715-Ab-1/ GM-Tg-hg-IP1715-Ab-2 | Anti-Human SLC35E2B monoclonal antibody | Human |
GM-Tg-rg-IP1715-Ab-1/ GM-Tg-rg-IP1715-Ab-2 | Anti-Rat SLC35E2B monoclonal antibody | Rat |
GM-Tg-mg-IP1715-Ab-1/ GM-Tg-mg-IP1715-Ab-2 | Anti-Mouse SLC35E2B monoclonal antibody | Mouse |
GM-Tg-cynog-IP1715-Ab-1/ GM-Tg-cynog-IP1715-Ab-2 | Anti-Cynomolgus/ Rhesus macaque SLC35E2B monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP1715-Ab-1/ GM-Tg-felg-IP1715-Ab-2 | Anti-Feline SLC35E2B monoclonal antibody | Feline |
GM-Tg-cang-IP1715-Ab-1/ GM-Tg-cang-IP1715-Ab-2 | Anti-Canine SLC35E2B monoclonal antibody | Canine |
GM-Tg-bovg-IP1715-Ab-1/ GM-Tg-bovg-IP1715-Ab-2 | Anti-Bovine SLC35E2B monoclonal antibody | Bovine |
GM-Tg-equg-IP1715-Ab-1/ GM-Tg-equg-IP1715-Ab-2 | Anti-Equine SLC35E2B monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP1715-Ab-1/ GM-Tg-hg-IP1715-Ab-2; GM-Tg-rg-IP1715-Ab-1/ GM-Tg-rg-IP1715-Ab-2; GM-Tg-mg-IP1715-Ab-1/ GM-Tg-mg-IP1715-Ab-2; GM-Tg-cynog-IP1715-Ab-1/ GM-Tg-cynog-IP1715-Ab-2; GM-Tg-felg-IP1715-Ab-1/ GM-Tg-felg-IP1715-Ab-2; GM-Tg-cang-IP1715-Ab-1/ GM-Tg-cang-IP1715-Ab-2; GM-Tg-bovg-IP1715-Ab-1/ GM-Tg-bovg-IP1715-Ab-2; GM-Tg-equg-IP1715-Ab-1/ GM-Tg-equg-IP1715-Ab-2 |
Products Name | Anti-SLC35E2B monoclonal antibody |
Format | mab |
Target Name | SLC35E2B |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-SLC35E2B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP1715-Ag-1 | Recombinant multi-species S352B/ SLC35E2B/ SLC35E2 protein |
ORF Viral Vector | pGMLPm002623 | mouse Slc35e2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002623 | mouse Slc35e2 Lentivirus particle |
Target information
Target ID | GM-IP1715 |
Target Name | SLC35E2B |
Gene ID | 728661,320541,313765,100427470,101081205 |
Gene Symbol and Synonyms | A530082C11Rik,SLC35E2,Slc35e2a,SLC35E2B |
Uniprot Accession | P0CK96 |
Uniprot Entry Name | S352B_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000189339 |
Target Classification | N/A |
The target: SLC35E2B, gene name: SLC35E2B, also named as SLC35E2. Predicted to enable antiporter activity. Predicted to be involved in transmembrane transport. Predicted to act upstream of or within blastocyst hatching. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.